The global high-potent oral solid dosage contract manufacturing market is on the brink of a transformative decade, poised to witness remarkable expansion according to market research forecasts. Projections indicate a surge from USD 4.1 billion in 2023 to an estimated USD 8.6 billion by 2033, marking a robust Compound Annual Growth Rate (CAGR) of 7.6%. …
Tag Archives: High-Potent Oral Solid Dosage Contract Manufacturing Market
Global High-Potent Oral Solid Dosage Contract Manufacturing Market is slated to achieve a significant US$ 8.6 Billion valuation by 2033
The global high-potent oral solid dosage contract manufacturing industry demand is projected to witness substantial growth, surging from US$ 4.1 billion in 2023 to an estimated US$ 8.6 billion by 2033. This robust expansion, averaging a 7.6% Compound Annual Growth Rate (CAGR) throughout the forecast period, reflects the increasing demand for specialized facilities capable of …
High-Potent Oral Solid Dosage Contract Manufacturing Highly Demanding FMI Predicts the Market to Surpass US$ 8.6 Billion by 2033 | FMI
In 2023, the High-Potent Oral Solid Dosage Contract Manufacturing Market is expected to be worth US$ 4.1 billion. The market is expected to reach US$ 8.6 billion by 2033, expanding at a 7.6% CAGR throughout the forecast period. High-potent oral solid dosage forms, such as tablets and capsules, require specialized facilities and equipment to produce …